MovDisordV3, PascalFrancis, Corpus, bibRecord, 000032

Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study

Identifieur interne : 000032 ( PascalFrancis/Corpus ); précédent : 000031; suivant : 000033

Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study

Auteurs : Michele Poletti ; Giulio Perugi ; Chiara Logi ; Anna Romano ; Paolo Del Dotto ; Roberto Ceravolo ; Giuseppe Rossi ; Pasquale Pepe ; Liliana Dell'Osso ; Ubaldo Bonuccelli

Source :

Movement disorders [ 0885-3185 ] ; 2012.

RBID : Pascal:13-0017947

Descripteurs français

Pascal (Inist)
- Délire, Maladie de Parkinson, Démence, Pathologie du système nerveux, Stimulant dopaminergique, Etude transversale, Prévalence, Lévodopa.

English descriptors

KwdEn :
- Cross sectional study, Delusion, Dementia, Dopamine agonist, Levodopa, Nervous system diseases, Parkinson disease, Prevalence.

Abstract

Background: Delusional jealousy (DJ) has been described in patients with Parkinson's disease (PD) on dopaminergic therapy, but a role for dopaminergic therapy in DJ has not been established. Methods: The current cross-sectional study on DJ investigated its association with dopaminergic therapies compared with their associations with hallucinations and its prevalence in PD patients. Eight hundred five consecutive patients with PD were enrolled between January 2009 and June 2010. Results: DJ was identified in 20 patients (2.48%) and hallucinations in 193 patients (23.98%). In the multivariate logistic regression analyses, dopamine agonists were significantly associated with DJ (odds ratio, 18.1; 95% CI, 3.0-infinity; P = .0002) but not with hallucinations (odds ratio, 0.73; 95% CI, 0.49-1.10; P = .133). Conclusions: These findings suggest that dopamine agonist treatment represents a risk factor for DJ in PD independent of the presence of a dementing disorder, and the presence of this additional nonmotor side effect should be investigated in this clinical population.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 27`
A06				`@2 13`
A08	`01`	`1`	`ENG`	`@1 Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study`
A11	`01`	`1`		`@1 POLETTI (Michele)`
A11	`02`	`1`		`@1 PERUGI (Giulio)`
A11	`03`	`1`		`@1 LOGI (Chiara)`
A11	`04`	`1`		`@1 ROMANO (Anna)`
A11	`05`	`1`		`@1 DEL DOTTO (Paolo)`
A11	`06`	`1`		`@1 CERAVOLO (Roberto)`
A11	`07`	`1`		`@1 ROSSI (Giuseppe)`
A11	`08`	`1`		`@1 PEPE (Pasquale)`
A11	`09`	`1`		`@1 DELL'OSSO (Liliana)`
A11	`10`	`1`		`@1 BONUCCELLI (Ubaldo)`
A14	`01`			`@1 Department of Neuroscience, University of Pisa @2 Pisa @3 ITA @Z 1 aut. @Z 6 aut. @Z 10 aut.`
A14	`02`			`@1 Department of Psychiatry, University of Pisa @2 Pisa @3 ITA @Z 2 aut. @Z 4 aut. @Z 9 aut.`
A14	`03`			`@1 Neurology Unit, Hospital of Viareggio, USL 12 @2 Toscana @3 ITA @Z 3 aut. @Z 5 aut.`
A14	`04`			`@1 Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council @2 Pisa @3 ITA @Z 7 aut. @Z 8 aut.`
A20				`@1 1679-1682`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000505459050200`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 32 ref.`
A47	`01`	`1`		`@0 13-0017947`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Background: Delusional jealousy (DJ) has been described in patients with Parkinson's disease (PD) on dopaminergic therapy, but a role for dopaminergic therapy in DJ has not been established. Methods: The current cross-sectional study on DJ investigated its association with dopaminergic therapies compared with their associations with hallucinations and its prevalence in PD patients. Eight hundred five consecutive patients with PD were enrolled between January 2009 and June 2010. Results: DJ was identified in 20 patients (2.48%) and hallucinations in 193 patients (23.98%). In the multivariate logistic regression analyses, dopamine agonists were significantly associated with DJ (odds ratio, 18.1; 95% CI, 3.0-infinity; P = .0002) but not with hallucinations (odds ratio, 0.73; 95% CI, 0.49-1.10; P = .133). Conclusions: These findings suggest that dopamine agonist treatment represents a risk factor for DJ in PD independent of the presence of a dementing disorder, and the presence of this additional nonmotor side effect should be investigated in this clinical population.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Délire @5 01`
C03	`01`	`X`	`ENG`	`@0 Delusion @5 01`
C03	`01`	`X`	`SPA`	`@0 Delirio @5 01`
C03	`02`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 02`
C03	`03`	`X`	`FRE`	`@0 Démence @5 03`
C03	`03`	`X`	`ENG`	`@0 Dementia @5 03`
C03	`03`	`X`	`SPA`	`@0 Demencia @5 03`
C03	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 04`
C03	`04`	`X`	`ENG`	`@0 Nervous system diseases @5 04`
C03	`04`	`X`	`SPA`	`@0 Sistema nervioso patología @5 04`
C03	`05`	`X`	`FRE`	`@0 Stimulant dopaminergique @5 09`
C03	`05`	`X`	`ENG`	`@0 Dopamine agonist @5 09`
C03	`05`	`X`	`SPA`	`@0 Estimulante dopaminérgico @5 09`
C03	`06`	`X`	`FRE`	`@0 Etude transversale @5 10`
C03	`06`	`X`	`ENG`	`@0 Cross sectional study @5 10`
C03	`06`	`X`	`SPA`	`@0 Estudio transversal @5 10`
C03	`07`	`X`	`FRE`	`@0 Prévalence @5 11`
C03	`07`	`X`	`ENG`	`@0 Prevalence @5 11`
C03	`07`	`X`	`SPA`	`@0 Prevalencia @5 11`
C03	`08`	`X`	`FRE`	`@0 Lévodopa @2 NK @2 FR @5 12`
C03	`08`	`X`	`ENG`	`@0 Levodopa @2 NK @2 FR @5 12`
C03	`08`	`X`	`SPA`	`@0 Levodopa @2 NK @2 FR @5 12`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 007`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 13-0017947 INIST
ET :	Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study
AU :	POLETTI (Michele); PERUGI (Giulio); LOGI (Chiara); ROMANO (Anna); DEL DOTTO (Paolo); CERAVOLO (Roberto); ROSSI (Giuseppe); PEPE (Pasquale); DELL'OSSO (Liliana); BONUCCELLI (Ubaldo)
AF :	Department of Neuroscience, University of Pisa/Pisa/Italie (1 aut., 6 aut., 10 aut.); Department of Psychiatry, University of Pisa/Pisa/Italie (2 aut., 4 aut., 9 aut.); Neurology Unit, Hospital of Viareggio, USL 12/Toscana/Italie (3 aut., 5 aut.); Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council/Pisa/Italie (7 aut., 8 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2012; Vol. 27; No. 13; Pp. 1679-1682; Bibl. 32 ref.
LA :	Anglais
EA :	Background: Delusional jealousy (DJ) has been described in patients with Parkinson's disease (PD) on dopaminergic therapy, but a role for dopaminergic therapy in DJ has not been established. Methods: The current cross-sectional study on DJ investigated its association with dopaminergic therapies compared with their associations with hallucinations and its prevalence in PD patients. Eight hundred five consecutive patients with PD were enrolled between January 2009 and June 2010. Results: DJ was identified in 20 patients (2.48%) and hallucinations in 193 patients (23.98%). In the multivariate logistic regression analyses, dopamine agonists were significantly associated with DJ (odds ratio, 18.1; 95% CI, 3.0-infinity; P = .0002) but not with hallucinations (odds ratio, 0.73; 95% CI, 0.49-1.10; P = .133). Conclusions: These findings suggest that dopamine agonist treatment represents a risk factor for DJ in PD independent of the presence of a dementing disorder, and the presence of this additional nonmotor side effect should be investigated in this clinical population.
CC :	002B17; 002B17G
FD :	Délire; Maladie de Parkinson; Démence; Pathologie du système nerveux; Stimulant dopaminergique; Etude transversale; Prévalence; Lévodopa
FG :	Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central
ED :	Delusion; Parkinson disease; Dementia; Nervous system diseases; Dopamine agonist; Cross sectional study; Prevalence; Levodopa
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD :	Delirio; Parkinson enfermedad; Demencia; Sistema nervioso patología; Estimulante dopaminérgico; Estudio transversal; Prevalencia; Levodopa
LO :	INIST-20953.354000505459050200
ID :	13-0017947

Links to Exploration step

Pascal:13-0017947

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study</title>
<author><name sortKey="Poletti, Michele" sort="Poletti, Michele" uniqKey="Poletti M" first="Michele" last="Poletti">Michele Poletti</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Perugi, Giulio" sort="Perugi, Giulio" uniqKey="Perugi G" first="Giulio" last="Perugi">Giulio Perugi</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Logi, Chiara" sort="Logi, Chiara" uniqKey="Logi C" first="Chiara" last="Logi">Chiara Logi</name>
<affiliation><inist:fA14 i1="03"><s1>Neurology Unit, Hospital of Viareggio, USL 12</s1>
<s2>Toscana</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Romano, Anna" sort="Romano, Anna" uniqKey="Romano A" first="Anna" last="Romano">Anna Romano</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Del Dotto, Paolo" sort="Del Dotto, Paolo" uniqKey="Del Dotto P" first="Paolo" last="Del Dotto">Paolo Del Dotto</name>
<affiliation><inist:fA14 i1="03"><s1>Neurology Unit, Hospital of Viareggio, USL 12</s1>
<s2>Toscana</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ceravolo, Roberto" sort="Ceravolo, Roberto" uniqKey="Ceravolo R" first="Roberto" last="Ceravolo">Roberto Ceravolo</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rossi, Giuseppe" sort="Rossi, Giuseppe" uniqKey="Rossi G" first="Giuseppe" last="Rossi">Giuseppe Rossi</name>
<affiliation><inist:fA14 i1="04"><s1>Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pepe, Pasquale" sort="Pepe, Pasquale" uniqKey="Pepe P" first="Pasquale" last="Pepe">Pasquale Pepe</name>
<affiliation><inist:fA14 i1="04"><s1>Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dell Osso, Liliana" sort="Dell Osso, Liliana" uniqKey="Dell Osso L" first="Liliana" last="Dell'Osso">Liliana Dell'Osso</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0017947</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 13-0017947 INIST</idno>
<idno type="RBID">Pascal:13-0017947</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000032</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study</title>
<author><name sortKey="Poletti, Michele" sort="Poletti, Michele" uniqKey="Poletti M" first="Michele" last="Poletti">Michele Poletti</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Perugi, Giulio" sort="Perugi, Giulio" uniqKey="Perugi G" first="Giulio" last="Perugi">Giulio Perugi</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Logi, Chiara" sort="Logi, Chiara" uniqKey="Logi C" first="Chiara" last="Logi">Chiara Logi</name>
<affiliation><inist:fA14 i1="03"><s1>Neurology Unit, Hospital of Viareggio, USL 12</s1>
<s2>Toscana</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Romano, Anna" sort="Romano, Anna" uniqKey="Romano A" first="Anna" last="Romano">Anna Romano</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Del Dotto, Paolo" sort="Del Dotto, Paolo" uniqKey="Del Dotto P" first="Paolo" last="Del Dotto">Paolo Del Dotto</name>
<affiliation><inist:fA14 i1="03"><s1>Neurology Unit, Hospital of Viareggio, USL 12</s1>
<s2>Toscana</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ceravolo, Roberto" sort="Ceravolo, Roberto" uniqKey="Ceravolo R" first="Roberto" last="Ceravolo">Roberto Ceravolo</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rossi, Giuseppe" sort="Rossi, Giuseppe" uniqKey="Rossi G" first="Giuseppe" last="Rossi">Giuseppe Rossi</name>
<affiliation><inist:fA14 i1="04"><s1>Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pepe, Pasquale" sort="Pepe, Pasquale" uniqKey="Pepe P" first="Pasquale" last="Pepe">Pasquale Pepe</name>
<affiliation><inist:fA14 i1="04"><s1>Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dell Osso, Liliana" sort="Dell Osso, Liliana" uniqKey="Dell Osso L" first="Liliana" last="Dell'Osso">Liliana Dell'Osso</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cross sectional study</term>
<term>Delusion</term>
<term>Dementia</term>
<term>Dopamine agonist</term>
<term>Levodopa</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Délire</term>
<term>Maladie de Parkinson</term>
<term>Démence</term>
<term>Pathologie du   système nerveux</term>
<term>Stimulant dopaminergique</term>
<term>Etude transversale</term>
<term>Prévalence</term>
<term>Lévodopa</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Delusional jealousy (DJ) has been described in patients with Parkinson's disease (PD) on dopaminergic therapy, but a role for dopaminergic therapy in DJ has not been established. Methods: The current cross-sectional study on DJ investigated its association with dopaminergic therapies compared with their associations with hallucinations and its prevalence in PD patients. Eight hundred five consecutive patients with PD were enrolled between January 2009 and June 2010. Results: DJ was identified in 20 patients (2.48%) and hallucinations in 193 patients (23.98%). In the multivariate logistic regression analyses, dopamine agonists were significantly associated with DJ (odds ratio, 18.1; 95% CI, 3.0-infinity; P = .0002) but not with hallucinations (odds ratio, 0.73; 95% CI, 0.49-1.10; P = .133). Conclusions: These findings suggest that dopamine agonist treatment represents a risk factor for DJ in PD independent of the presence of a dementing disorder, and the presence of this additional nonmotor side effect should be investigated in this clinical population.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>27</s2>
</fA05>
<fA06><s2>13</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>POLETTI (Michele)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>PERUGI (Giulio)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LOGI (Chiara)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ROMANO (Anna)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DEL DOTTO (Paolo)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>CERAVOLO (Roberto)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>ROSSI (Giuseppe)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>PEPE (Pasquale)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DELL'OSSO (Liliana)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>BONUCCELLI (Ubaldo)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neuroscience, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Psychiatry, University of Pisa</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Neurology Unit, Hospital of Viareggio, USL 12</s1>
<s2>Toscana</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council</s1>
<s2>Pisa</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>1679-1682</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000505459050200</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0017947</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background: Delusional jealousy (DJ) has been described in patients with Parkinson's disease (PD) on dopaminergic therapy, but a role for dopaminergic therapy in DJ has not been established. Methods: The current cross-sectional study on DJ investigated its association with dopaminergic therapies compared with their associations with hallucinations and its prevalence in PD patients. Eight hundred five consecutive patients with PD were enrolled between January 2009 and June 2010. Results: DJ was identified in 20 patients (2.48%) and hallucinations in 193 patients (23.98%). In the multivariate logistic regression analyses, dopamine agonists were significantly associated with DJ (odds ratio, 18.1; 95% CI, 3.0-infinity; P = .0002) but not with hallucinations (odds ratio, 0.73; 95% CI, 0.49-1.10; P = .133). Conclusions: These findings suggest that dopamine agonist treatment represents a risk factor for DJ in PD independent of the presence of a dementing disorder, and the presence of this additional nonmotor side effect should be investigated in this clinical population.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Délire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Delusion</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Delirio</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Démence</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Dementia</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Demencia</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Stimulant dopaminergique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Dopamine agonist</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estimulante dopaminérgico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Etude transversale</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Cross sectional study</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Estudio transversal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Prévalence</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Prevalence</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Prevalencia</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Lévodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>007</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 13-0017947 INIST</NO>
<ET>Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study</ET>
<AU>POLETTI (Michele); PERUGI (Giulio); LOGI (Chiara); ROMANO (Anna); DEL DOTTO (Paolo); CERAVOLO (Roberto); ROSSI (Giuseppe); PEPE (Pasquale); DELL'OSSO (Liliana); BONUCCELLI (Ubaldo)</AU>
<AF>Department of Neuroscience, University of Pisa/Pisa/Italie (1 aut., 6 aut., 10 aut.); Department of Psychiatry, University of Pisa/Pisa/Italie (2 aut., 4 aut., 9 aut.); Neurology Unit, Hospital of Viareggio, USL 12/Toscana/Italie (3 aut., 5 aut.); Unit of Epidemiology and Biostatistics, Institute of Clinical Physiology, National Research Council/Pisa/Italie (7 aut., 8 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2012; Vol. 27; No. 13; Pp. 1679-1682; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>Background: Delusional jealousy (DJ) has been described in patients with Parkinson's disease (PD) on dopaminergic therapy, but a role for dopaminergic therapy in DJ has not been established. Methods: The current cross-sectional study on DJ investigated its association with dopaminergic therapies compared with their associations with hallucinations and its prevalence in PD patients. Eight hundred five consecutive patients with PD were enrolled between January 2009 and June 2010. Results: DJ was identified in 20 patients (2.48%) and hallucinations in 193 patients (23.98%). In the multivariate logistic regression analyses, dopamine agonists were significantly associated with DJ (odds ratio, 18.1; 95% CI, 3.0-infinity; P = .0002) but not with hallucinations (odds ratio, 0.73; 95% CI, 0.49-1.10; P = .133). Conclusions: These findings suggest that dopamine agonist treatment represents a risk factor for DJ in PD independent of the presence of a dementing disorder, and the presence of this additional nonmotor side effect should be investigated in this clinical population.</EA>
<CC>002B17; 002B17G</CC>
<FD>Délire; Maladie de Parkinson; Démence; Pathologie du système nerveux; Stimulant dopaminergique; Etude transversale; Prévalence; Lévodopa</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du   système nerveux central</FG>
<ED>Delusion; Parkinson disease; Dementia; Nervous system diseases; Dopamine agonist; Cross sectional study; Prevalence; Levodopa</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Delirio; Parkinson enfermedad; Demencia; Sistema nervioso patología; Estimulante dopaminérgico; Estudio transversal; Prevalencia; Levodopa</SD>
<LO>INIST-20953.354000505459050200</LO>
<ID>13-0017947</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000032 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000032 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0017947
   |texte=   Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study

Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri